Empirical evidence on the trade impact of asynchronous regulatory approval of new GMO events

Faria, Rosane Nunes de; Wieck, Christine

doi:10.1016/j.foodpol.2015.03.005

Cited by 20 publications

(24 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Delays in authorising GE crops postpone their benefits and cause economic losses in foregone profits. Losses are further exaggerated by asynchronous approval processes, which cause market disruptions (Vigani et al ., ), and lead to strained trading relations (Henseler et al ., ; De Steur et al ., ; de Faria and Wieck, ) that in some cases have escalated to formal international disputes (Punt and Wesseler, ). Potential environmental and human health benefits are also delayed (Wesseler et al ., ).…”

Section: Introductionmentioning

confidence: 99%

Trends in Approval Times for Genetically Engineered Crops in the United States and the European Union

Smart

Blum²,

Wesseler

2016

J Agricultural Economics

View full text Add to dashboard Cite

Genetically engineered (GE) crops are subject to regulatory oversight to ensure their safety for humans and the environment. Their approval in the European Union (EU) starts with an application in a given Member State followed by a scientific risk assessment, and ends with a political decision‐making step (risk management). In the United States (US) approval begins with a scientific (field trial) step and ends with a ‘bureaucratic’ decision‐making step. We investigate trends for the time taken for these steps and the overall time taken for approving GE crops in the US and the EU. Our results show that from 1996–2015 the overall time trend for approval in the EU decreased and then flattened off, with an overall mean completion‐time of 1,763 days. In the US in 1998 there was a break in the trend of the overall approval time. Initially, from 1988 until 1997 the trend decreased with a mean approval time of 1,321 days; from 1998–2015, the trend almost stagnated with a mean approval time of 2,467 days.

show abstract

Section: Introductionmentioning

confidence: 99%

Trends in Approval Times for Genetically Engineered Crops in the United States and the European Union

Smart

Blum²,

Wesseler

2016

J Agricultural Economics

View full text Add to dashboard Cite

show abstract

“…Of the 50 imported GM crop varieties approved, 46 were previously approved in the USA, and 47 in Canada. This policy results in approval asynchronicity and creates an invisible delay with significant trade impacts [6]. Figure 1B shows that in China the same GM variety is approved on average 1544 days (4.2 years) after it has been approved in the USA, and 1783 days (4.9 years) after approval in Canada.…”

Section: China Compared With Other Countriesmentioning

confidence: 99%

Getting an Imported GM Crop Approved in China

Jia-Ren

Drábik

Heerink

et al. 2019

Trends in Biotechnology

View full text Add to dashboard Cite

show abstract

“…A major challenge is the current regulatory heterogeneity on biotechnology and its outcomes. Due to a variety of political stances on biotechnology, approval of a new biotechnology product does not occur simultaneously across trade partners and their regulatory systems [40].…”

Section: Establishing Regulatory Systems For Agricultural Biotechnologymentioning

confidence: 99%

Capacity Building for Agricultural Biotechnology in Developing Countries

Lee¹

2018

TOASJ

View full text Add to dashboard Cite

Introduction:Agricultural biotechnology holds a unique position in formulating food and trade policies due to its conflicting aspects: its potential to improve food security especially in developing countries, and the intense debates over its risks and unknown impacts on human health and the environment. Agricultural biotechnology, nevertheless, has been widely utilized to help enhance food security with its extensive applications.Explanation:The technology is knowledge-resource intensive, therefore reinforcing a gap between developed and developing countries. One of the critical determinants of availability and accessibility of the technology is a developing country’s own capacity. Developing countries that wish to benefit the technology should build sufficient capacity. The current study intends to review the concepts of capacity building in agricultural biotechnology, and identify areas frequently considered in need of capacity building; coordinating partnerships, making financial commitment, setting priorities, establishing a regulatory system, and building public awareness.Conclusion:While each area has its own territory, they juxtapose on one another to some extends, which can act as a virtuous or vicious cycle to facilitate or obstruct capacity building. Programs for successful capacity building in agricultural biotechnology should consider this nature.

show abstract

Empirical evidence on the trade impact of asynchronous regulatory approval of new GMO events

Cited by 20 publications

References 22 publications

Trends in Approval Times for Genetically Engineered Crops in the United States and the European Union

Trends in Approval Times for Genetically Engineered Crops in the United States and the European Union

Getting an Imported GM Crop Approved in China

Capacity Building for Agricultural Biotechnology in Developing Countries

Contact Info

Product

Resources

About